Literature DB >> 23978525

Truncation of PstS1 antigen of Mycobacterium tuberculosis improves diagnostic efficiency.

Sana Khurshid1, Ruqyya Khalid, Madeeha Afzal, M Waheed Akhtar.   

Abstract

PstS1, also named 38-kDa antigen, is one of the earliest known immune-dominant antigens of Mycobacterium tuberculosis and it has been commonly used in serodiagnostic tests. We constructed a truncated version, tnPstS1, by removing 96 and 14 amino acid residues from the N- and C-terminals, respectively of the native PstS1. The native and the truncated 29.5 kDa proteins were expressed in insoluble forms in Escherichia coli to levels of 15% and 25% of the total cell proteins, respectively. Both the variant molecules reacted equally well with the antisera raised in rabbit against the native protein. PstS1 and tnPstS1 were evaluated through ELISA against plasma samples from 160 culture positive tuberculosis patients and 40 healthy controls. With tnPstS1 43% of the patient samples were detected positive for the antibody as compared to only 36% in the case of the native PstS1. Data for the secondary structures of the native and the truncated variants as obtained by circular dichroism agreed with the known 3-D structure of the native protein and the predicted structure of the truncated version, respectively. The results show that the truncated tnPstS1 is more efficient as compared to the native PstS1 for use as a serodiagnostic agent.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mycobacterium tuberculosis; PstS1; Tuberculosis; tnPstS1

Mesh:

Substances:

Year:  2013        PMID: 23978525     DOI: 10.1016/j.tube.2013.07.005

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  7 in total

1.  A systematic review of biomarkers to detect active tuberculosis.

Authors:  Emily MacLean; Tobias Broger; Seda Yerlikaya; B Leticia Fernandez-Carballo; Madhukar Pai; Claudia M Denkinger
Journal:  Nat Microbiol       Date:  2019-02-25       Impact factor: 17.745

2.  Close contact interferon-gamma response to the new PstS1(285-374):CPF10: a preliminary 1-year follow-up study.

Authors:  Leonardo Silva de Araujo; Nidai de Bárbara Moreira da Silva Lins; Janaina Aparecida Medeiros Leung; Fernanda Carvalho Queiroz Mello; Maria Helena Féres Saad
Journal:  BMC Res Notes       Date:  2017-01-23

3.  Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis.

Authors:  Sadaf Sulman; Saher Shahid; Aasia Khaliq; Atiqa Ambreen; Imran H Khan; Andrea M Cooper; Muhammad Waheed Akhtar
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

4.  Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response.

Authors:  Shaista Arif; Mohsina Akhter; Aasia Khaliq; Muhammad Waheed Akhtar
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

5.  Balance between Protection and Pathogenic Response to Aerosol Challenge with Mycobacterium tuberculosis (Mtb) in Mice Vaccinated with TriFu64, a Fusion Consisting of Three Mtb Antigens.

Authors:  Sadaf Sulman; Benjamin O Savidge; Kawther Alqaseer; Mrinal K Das; Neda Nezam Abadi; John E Pearl; Obolbek Turapov; Galina V Mukamolova; M Waheed Akhtar; Andrea May Cooper
Journal:  Vaccines (Basel)       Date:  2021-05-18

6.  Fusion Molecules of Heat Shock Protein HSPX with Other Antigens of Mycobacterium tuberculosis Show High Potential in Serodiagnosis of Tuberculosis.

Authors:  Ruqyya Khalid; Madeeha Afzal; Sana Khurshid; Rehan Zafar Paracha; Imran H Khan; Muhammad Waheed Akhtar
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

7.  Analysis of recombinant proteins for Q fever diagnostics.

Authors:  Halie K Miller; Gilbert J Kersh
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.